Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Angel D who wrote (1376)	9/30/1999 9:42:00 AM
From: CMon	Read Replies (1) \| Respond to of 1432

Huh? What're you smoking? "BTX receives FDA approval in less than expected time frame". Old news. Straw man argument. In the stock already. "ABT pays royalty to BTX for 'unlimited' label." Another straw man. The competing products label is "unlimited" in the same way. Read it. But then again: also an old argument, also in the stock. "ABT to 'launch' Hextend at anesthesiologists convention in October". Oh. OK. Let's launch AGAIN to give yet another date to look forward to. Again: in the stock already. In sum: it's in the stock. And where's the stock again? Answer: lower than it was beofre the hypesters, promoters, and fools who told us to lok forward to the "stock moving" announcements. Another good thing about the lower post-count on the SI thread is that it makes it easy to reread the history. Reread this thread for the past year or two. Who's bleeding?